Literature DB >> 20003643

Impact of bovine respiratory disease (BRD) from the perspective of the Canadian beef producer.

Kee Jim1.   

Abstract

The costs of bovine respiratory disease (BRD) to the beef producer can be estimated by identifying and summing the direct and indirect costs associated with the disease. The major direct costs are attributable to the cost of the feeder, production costs and carcass disposal. The indirect costs are mainly associated with infrastructure and labour.

Entities:  

Mesh:

Year:  2009        PMID: 20003643     DOI: 10.1017/S1466252309990119

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  4 in total

1.  Limited efficacy of Fever Tag(®) temperature sensing ear tags in calves with naturally occurring bovine respiratory disease or induced bovine viral diarrhea virus infection.

Authors:  Robert McCorkell; Katherine Wynne-Edwards; Claire Windeyer; Al Schaefer
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  Prevalence and Risk Factors Associated With Antimicrobial Resistance in Bacteria Related to Bovine Respiratory Disease-A Broad Cross-Sectional Study of Beef Cattle at Entry Into Canadian Feedlots.

Authors:  Sara Andrés-Lasheras; Reuben Ha; Rahat Zaheer; Catrione Lee; Calvin W Booker; Craig Dorin; Joyce Van Donkersgoed; Rob Deardon; Sheryl Gow; Sherry J Hannon; Steve Hendrick; Michele Anholt; Tim A McAllister
Journal:  Front Vet Sci       Date:  2021-07-01

3.  Economic impact of digital dermatitis, foot rot, and bovine respiratory disease in feedlot cattle.

Authors:  Julian Alberto Cortes; Steve Hendrick; Eugene Janzen; Ed A Pajor; Karin Orsel
Journal:  Transl Anim Sci       Date:  2021-05-19

Review 4.  Systematic Review of the Diagnostic Accuracy of Haptoglobin, Serum Amyloid A, and Fibrinogen versus Clinical Reference Standards for the Diagnosis of Bovine Respiratory Disease.

Authors:  A Abdallah; J Hewson; D Francoz; H Selim; S Buczinski
Journal:  J Vet Intern Med       Date:  2016-06-03       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.